Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06472388
Title Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (EVENET)
Acronym EVENET
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AC Camargo Cancer Center
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries

Facility Status City State Zip Country Details
AC Camargo Cancer Center RECRUITING São Paulo SP 01509010 Brazil Details
AC Camargo Cancer Center RECRUITING Sao Paulo 01509010 Brazil Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field